🇰🇷 Sodium Nitroprusside in South Korea

Sodium Nitroprusside (NITROPRUSSIDE) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Sodium Nitroprusside in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Cardiovascular approved in South Korea

Frequently asked questions

Is Sodium Nitroprusside approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Sodium Nitroprusside in South Korea?

Roche is the originator. The local marketing authorisation holder may differ — check the official source linked above.